Loading clinical trials...
Loading clinical trials...
To learn if applying vapocoolant anesthetic spray ("Nüm") on the surface of the intended injection site will reduce the pain/anxiety associated with breast injections.
Primary Objectives: 1. Establish feasibility of topical vapocoolant in the setting of breast lymphoscintigraphy. 2. Demonstrate safety of topical vapocoolant in the setting of breast lymphoscintigraphy. Secondary Objectives: 1. To assess patient pain intensity associated with the performance of breast lymphoscintigraphy. 2. To evaluate the attitude from patients about supporting the continued offering of topical vapocoolant in the breast lymphoscintigraphy clinic.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
MD Anderson Cancer Center
Houston, Texas, United States
Start Date
March 1, 2023
Primary Completion Date
May 13, 2025
Completion Date
May 13, 2025
Last Updated
May 20, 2025
30
ACTUAL participants
num Vapocoolant
OTHER
Lead Sponsor
M.D. Anderson Cancer Center
Collaborators
NCT05673200
NCT05372640
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions